Home › Funds › Parkman Healthcare Partners LLC › THC
Parkman Healthcare Partners LLC position in THC
TENET HEALTHCARE CORP · Health Care
Parkman Healthcare Partners LLC reported holding 63,854 shares of THC (TENET HEALTHCARE CORP) in its Q3 2026 13F filing — a position valued at US$16.3M, representing 1.47% of its reported portfolio and ranking #24 among its reported holdings. Parkman Healthcare Partners LLC has disclosed THC holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Parkman Healthcare Partners LLC's THC position evolved
Parkman Healthcare Partners LLC first disclosed a stake in THC in Q3 2023 at 226,141 shares (US$14.9M). The position peaked in Q1 2024 at 283,853 shares, worth US$29.8M. Across 13 filings, Parkman Healthcare Partners LLC increased the stake 4 time(s), trimmed it 8 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 63,854 shares valued at US$16.3M — a reduction of -33,426 shares quarter over quarter.. Notable position changes include a 58% increase in Q4 2023 (shares rose 39% over the following quarter), a 99% increase in Q1 2025 (shares rose 31% over the following quarter), a 94% increase in Q2 2026 (shares rose 37% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 226.14K | $14.90M | New |
| Q4 2023 | 356.81K | $26.96M | Add |
| Q1 2024 | 283.85K | $29.84M | Reduce |
| Q2 2024 | 148.93K | $19.81M | Reduce |
| Q3 2024 | 93.75K | $15.58M | Reduce |
| Q4 2024 | 106.99K | $13.50M | Add |
| Q1 2025 | 213.42K | $28.70M | Add |
| Q2 2025 | 168.88K | $29.72M | Reduce |
| Q3 2025 | 74.33K | $15.09M | Reduce |
| Q4 2025 | 60.51K | $12.03M | Reduce |
| Q1 2026 | 50.12K | $9.46M | Reduce |
| Q2 2026 | 97.28K | $18.20M | Add |
| Q3 2026 | 63.85K | $16.32M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About THC and 13F data
THC (TENET HEALTHCARE CORP) is a Health Care company. 35 other funds we track also report a position in THC — the largest reported positions include Boston Partners (US$1.04B), GLENVIEW CAPITAL MANAGEMENT, LLC (US$418.2M), MANNING & NAPIER ADVISORS LLC (US$153.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding THC
- Boston Partners 4.06M sh · $1.04B · Q3 2026
- GLENVIEW CAPITAL MANAGEMENT, LLC 2.24M sh · $418.25M · Q2 2026
- MANNING & NAPIER ADVISORS LLC 562.72K sh · $153.76M · Q3 2026
- EMINENCE CAPITAL, LP 790.30K sh · $149.14M · Q1 2026
More on Parkman Healthcare Partners LLC
FAQ
How long has Parkman Healthcare Partners LLC held THC?
Parkman Healthcare Partners LLC has disclosed THC holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Parkman Healthcare Partners LLC's current position in THC?
As of Q3 2026, Parkman Healthcare Partners LLC holds 63.85K shares of THC (TENET HEALTHCARE CORP), valued at $16.32M, representing 1.47% of its reported portfolio and ranking #24.
Has Parkman Healthcare Partners LLC been buying or selling THC?
In the latest 13F filing (Q3 2026), Parkman Healthcare Partners LLC reduced its position in THC. The position peaked in Q1 2024 at 283.85K shares.
Which other funds hold THC?
Other major institutional holders of THC include Boston Partners, GLENVIEW CAPITAL MANAGEMENT, LLC, MANNING & NAPIER ADVISORS LLC, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.